Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Amedis Pharmaceuticals Ltd.

Division of Takeda Pharmaceutical Co. Ltd.

Latest From Amedis Pharmaceuticals Ltd.

George Freeman Departure Leaves UK Life Sciences Holding Its Breath

Theresa May has re-structured the Department of Health ministerial team as part of her wide-ranging reshuffle and in so doing moved life sciences minister George Freeman over to chair the prime minister’s policy board. The British biopharma community says it hopes he will be replaced – and soon.

United Kingdom Policy

Goodbye, Blue Sky: Shortcutting Discovery

A handful of European biotechnology companies is embracing development shortcuts that were once the exclusive provenance of specialty pharmaceutical firms. Shedding traditional biotech start-up discovery models, these firms aim to identify, reformulate and incrementally improve existing products. The hope is that low risk needn't be low reward; in the process these so-called reprofilers of existing therapies may indeed spark an increase in industry productivity. The trick, observers say, is finding and getting their hands on the right products.
BioPharmaceutical Europe

Amedis Pharmaceuticals Ltd.

Amedis Pharmaceuticals Ltd., based in Cambridge, UK, has developed a range of tools designed to help overcome the bottleneck in the drug development process. Established in April 2000, teh company has devised two core platform technologies based on a combination of chemistry, biology and bioinformatics.
BioPharmaceutical Europe
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • ADMET
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Cancer
  • Dermatology
  • Gastrointestinal
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Takeda Pharmaceutical Co. Ltd.
  • Senior Management
  • John Montana, CEO
    Malcolm Hay, CFO
    William Bains, PhD, CSO
  • Contact Info
  • Amedis Pharmaceuticals Ltd.
    Phone: (44) 223 477910
    Cambridge Science Park, Unit 209
    Milton Rd.
    Cambridge, CB4 0GZ